Comparison of the molecular classification with FIGO stage and histological grade on endometrial cancer

European Journal of Gynaecological Oncology

Volumn 28, Issue 6, 2007, Pages 451-460

  Cai, B ^a   Liu, L ^a,b   Xi, X W ^a   Zhu, Y P ^a   Lu, G Z ^a   Yang, Y X ^a   Wan, X P ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Classification; Endometrial carcinoma; Gene expression profiling; Prognosis

Indexed keywords

COMPLEMENTARY DNA; DNA;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DNA FINGERPRINTING; DNA MICROARRAY; ENDOMETRIUM CANCER; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC VARIABILITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MOLECULAR DYNAMICS; NUCLEOTIDE SEQUENCE; TUMOR GENE; UNINDEXED SEQUENCE;

ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; DNA PRIMERS; DNA, COMPLEMENTARY; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION;

EID: 37749044597     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Amant F., Moerman P., Neven P., Timmerman D., Van Limbergen E., Vergote I.: "Endometrial cancer". Lancet, 2005, 366, 491.
2. American College of Obstetricians and Gynecologists: "ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer". Obstet. Gynecol., 2005, 106, 413.
3. Bucca G., Carruba G., Saetta A., Muti P., Castagnetta L., Smith C.P.: "Gene expression profiling of human cancers". Ann. N Y Acad Sci., 2004, 1028, 28.
4. Quackenbush J.: "Microarray analysis and tumor classification". N. Engl. J. Med., 2006, 354, 2463.
5. Sorlie T., Perou C.M., Tibshirani R., Aas T., Geisler S., Johnsen H. et al.: "Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications". Proc. Natl. Acad. Sci. USA, 2001, 98, 10869.
6. Alizadeh A.A., Eisen M.B., Davis R.E., Ma C., Lossos I.S,. Rosenwald A. et al.: "Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling". Nature, 2000, 403, 503.
7. Dave S.S., Fu K., Wright G.W., Lam L.T., Kluin P., Boerma E.J. et al.: "Molecular diagnosis of Burkitt's lymphoma". N. Engl. J. Med., 2006, 354, 2431.
8. van't Veer L.J., Dai H., van de Vijver M.J., He Y.D., Hart A.A., Mao M. et al.: "Gene expression profiling predicts clinical outcome of breast cancer". Nature, 2002, 415, 530.
9. Ouellet V., Provencher D.M., Maugard C.M., Le Page C., Ren F., Lussier C. et al.: "Discrimination between serous low malignant potential and invasive epithelial ovarian tumors using molecular profiling". Oncogene, 2005, 24, 4672.
10. Eisen M.B., Spellman P.T., Brown P.O., Botstein D.: "Cluster analysis and display of genome-wide expression patterns". Proc. Natl. Acad. Sci USA, 1998, 95, 14863.
11. Kitchener H.: "Management of endometrial cancer". Eur. J. Surg. Oncol., 2006, 32, 838.
12. Mutter G.L., Baak J.P., Fitzgerald J.T. et al.: "Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation". Gynecol. Oncol., 2001, 83, 177.
13. Gunter Kieback D., Fischer D.C.: "Gene expression profile in endometrioid endometrial carcinoma". Gynecol. Oncol., 2001, 83, 175.
14. Planaguma J., Diaz-Fuertes M., Gil-Moreno A., Abal M., Monge M., Garcia A. et al.: "A differential gene expression profile reveals overexpression of RUNX1/AML1 in invasive endometrioid carcinoma". Cancer Res., 2004, 64, 8846.
15. Smid-Koopman E., Blok L.J., Heimerhorst T.J., Chadha-Ajwani S., Burger C.W., Brinkmann A.O. et al.: "Gene expression profiling in human endometrial cancer tissue samples: utility and diagnostic value". Gynecol. Oncol., 2004, 93, 292.
16. Ferguson S.E., Olshen A.B., Viale A., Awtrey C.S., Barakat R.R., Boyd J.: "Gene expression profiling of tamoxifen-associated uterine cancers: evidence for two molecular classes of endometrial carcinoma". Gynecol. Oncol., 2004, 92, 719.
17. Risinger J.I., Maxwell G.L., Chandramouli G.V., Jazaeri A., Aprelikova O., Patterson T. et al.: "Microarray analysis reveals distinct gene expression profiles among different histologic types of endometrial cancer". Cancer Res., 2003, 63, 6.
18. Maxwell G.L., Chandramouli G.V., Dainty L., Litzi T.J., Berchuck A., Barrett J.C. et al.: "Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer". Clin. Cancer Res., 2005, 11, 4056.
19. Bidus M.A., Risinger J.I., Chandramouli G.V., Dainty L.A., Litzi T.J., Berchuck A. et al.: "Prediction of lymph node metastasis in patients with endometrioid endometrial cancer using expression microarray". Clin. Cancer Res., 2006, 12, 83.
20. Ferguson S.E., Olshen A.B., Viale A., Barakat R.R., Boyd J.: "Stratification of intermediate-risk endometrial cancer patients into groups at high risk or low risk for recurrence based on tumor gene expression profiles". Clin. Cancer Res., 2005, 11, 2252.
21. Takahashi S., Hasebe T., Oda T., Sasaki S., Kinoshita T., Konishi M. et al.: "Cytoplasmic expression of laminin gamma2 chain correlates with postoperative hepatic metastasis and poor prognosis in patients with pancreatic ductal adenocarcinoma". Cancer, 2002, 94, 1894.
22. Hofer M.D., Kuefer R., Varambally S., Li H., Ma J., Shapiro G.I. et al.: "The role of metastasis-associated protein 1 in prostate cancer progression". Cancer Res., 2004, 64, 825.
23. Byrne J.A., Balleine R.L., Schoenberg Fejzo M., Mercieca J., Chiew Y.E., Livnat Y. et al.: "Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer". Int. J. Cancer, 2005, 117, 1049.
24. Yamamura J., Miyoshi Y., Tamaki Y., Taguchi T., Iwao K., Monden M. et al.: "mRNA expression level of estrogen-inducible gene, alpha 1-antichymotrypsin, is a predictor of early tumor recurrence in patients with invasive breast cancers". Cancer Sci., 2004, 95, 887.
25. Park K., Kim K., Rho S.B., Choi K., Kim D., Oh S.H. et al.: "Homeobox Msx1 interacts with p53 tumor suppressor and inhibits tumor growth by inducing apoptosis". Cancer Res., 2005, 65, 749.
26. Kawamura-Tsuzuku J., Suzuki T., Yoshida Y., Yamamoto T.: "Nuclear localization of Tob is important for regulation of its antiproliferative activity". Oncogene, 2004, 23, 6630.
27. Wang L., Yu J., Ni J., Xu X.M., Wang J., Ning H. et al.: "Extracellular matrix protein 1 (ECM1) is over-expressed in malignant epithelial tumors". Cancer Lett., 2003, 200, 57.